The loss of the trans-sarcolemmal linkage via the dystrophin/dystroglycan sub-complex is the key trigger of membrane micro-rupturing in dystrophinopathies. This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.